Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2

Endocrine

Volumn 48, Issue 2, 2015, Pages 566-574

  Guan, Hongyu ^a   Liang, Weiwei ^a   Xie, Zhiwei ^b   Li, Hai ^a   Liu, Juan ^a   Liu, Liehua ^a   Xiu, Lingling ^a   Li, Yanbing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Chinese Christian High School   (United States)

Author keywords

Invasion; miR 144; Thyroid cancer; ZEB1; ZEB2

Indexed keywords

HOMEODOMAIN PROTEIN; MICRORNA; MIRN144 MICRORNA, HUMAN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN;

DOWN REGULATION; HUMAN; METABOLISM; PATHOLOGY; THYROID GLAND; THYROID TUMOR; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; DOWN-REGULATION; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; REPRESSOR PROTEINS; THYROID GLAND; THYROID NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84935441071     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0326-7     Document Type: Article

References (40)

1. M. Xing, B.R. Haugen, M. Schlumberger, Progress in molecular-based management of differentiated thyroid cancer. Lancet 381, 1058–1069 (2013)
2. S.I. Sherman, Thyroid carcinoma. Lancet 361, 501–511 (2003)
3. V.V. Vasko, M. Saji, Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Curr. Opin. Oncol. 19, 11–17 (2007)
4. Q. Yang, M. Ji, H. Guan, B. Shi, P. Hou, Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways. J. Clin. Endocrinol. Metab. 98, E1909–E1917 (2013)
5. V. Ambros, Micrornas: tiny regulators with great potential. Cell 107, 823–826 (2001)
6. X.S. Ke, C.M. Liu, D.P. Liu, C.C. Liang, Micrornas: key participants in gene regulatory networks. Curr. Opin. Chem. Biol. 7, 516–523 (2003)
7. G.A. Calin, C.M. Croce, Microrna signatures in human cancers. Nat. Rev. Cancer 6, 857–866 (2006)
8. C.Z. Chen, Micrornas as oncogenes and tumor suppressors. N. Engl. J. Med. 353, 1768–1771 (2005)
9. A. de la Chapelle, K. Jazdzewski, Micrornas in thyroid cancer. J. Clin. Endocrinol. Metab. 96, 3326–3336 (2011)
10. H. He, K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia, G.A. Calin, C.G. Liu, K. Franssila, S. Suster, R.T. Kloos, C.M. Croce, A. de la Chapelle, The role of microrna genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA 102, 19075–19080 (2005)
11. J.C. Ricarte-Filho, C.S. Fuziwara, A.S. Yamashita, E. Rezende, M.J. da-Silva, E.T. Kimura, Effects of let-7 microrna on cell growth and differentiation of papillary thyroid cancer. Transl. Oncol. 2, 236–241 (2009)
12. H.M. Namlos, L.A. Meza-Zepeda, T. Baroy, I.H. Ostensen, S.H. Kresse, M.L. Kuijjer, M. Serra, H. Burger, A.M. Cleton-Jansen, O. Myklebost, Modulation of the osteosarcoma expression phenotype by micrornas. PLoS One 7, e48086 (2012)
13. M. Guled, L. Lahti, P.M. Lindholm, K. Salmenkivi, I. Bagwan, A.G. Nicholson, S. Knuutila, Cdkn2a, nf2, and jun are dysregulated among other genes by mirnas in malignant mesothelioma-a mirna microarray analysis. Genes Chromosome Cancer 48, 615–623 (2009)
14. S. Akiyoshi, T. Fukagawa, H. Ueo, M. Ishibashi, Y. Takahashi, M. Fabbri, M. Sasako, Y. Maehara, K. Mimori, M. Mori, Clinical significance of mir-144-zfx axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br. J. Cancer 107, 1345–1353 (2012)
15. S.M. Sureban, R. May, F.G. Mondalek, D. Qu, S. Ponnurangam, P. Pantazis, S. Anant, R.P. Ramanujam, C.W. Houchen, Nanoparticle-based delivery of sidcamkl-1 increases microrna-144 and inhibits colorectal cancer tumor growth via a notch-1 dependent mechanism. J. Nanobiotechnol. 9, 40 (2011)
16. L.Y. Zhang, V. Ho-Fun Lee, A.M. Wong, D.L. Kwong, Y.H. Zhu, S.S. Dong, K.L. Kong, J. Chen, S.W. Tsao, X.Y. Guan, L. Fu, Microrna-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of pten. Carcinogenesis 34, 454–463 (2013)
17. S. Cahill, P. Smyth, K. Denning, R. Flavin, J. Li, A. Potratz, S.M. Guenther, R. Henfrey, J.J. O’Leary, O. Sheils, Effect of brafv600e mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Mol. Cancer 6, 21 (2007)
18. M. Rossing, R. Borup, R. Henao, O. Winther, J. Vikesaa, O. Niazi, C. Godballe, A. Krogdahl, M. Glud, C. Hjort-Sorensen, K. Kiss, F.N. Bennedbaek, F.C. Nielsen, Down-regulation of micrornas controlling tumourigenic factors in follicular thyroid carcinoma. J. Mol. Endocrinol. 48, 11–23 (2012)
19. M. Swierniak, A. Wojcicka, M. Czetwertynska, E. Stachlewska, M. Maciag, W. Wiechno, B. Gornicka, M. Bogdanska, L. Koperski, A. de la Chapelle, K. Jazdzewski, In-depth characterization of the microrna transcriptome in normal thyroid and papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, E1401–E1409 (2013)
20. S. Brabletz, T. Brabletz, The zeb/mir-200 feedback loop—a motor of cellular plasticity in development and cancer? EMBO Rep. 11, 670–677 (2010)
21. E.M. Hurt, J.N. Saykally, B.M. Anose, K.R. Kalli, M.M. Sanders, Expression of the zeb1 (deltaef1) transcription factor in human: additional insights. Mol. Cell. Biochem. 318, 89–99 (2008)
22. J. Comijn, G. Berx, P. Vermassen, K. Verschueren, L. van Grunsven, E. Bruyneel, M. Mareel, D. Huylebroeck, F. van Roy, The two-handed e box binding zinc finger protein sip1 downregulates e-cadherin and induces invasion. Mol. Cell 7, 1267–1278 (2001)
23. K. Aigner, L. Descovich, M. Mikula, A. Sultan, B. Dampier, S. Bonne, F. van Roy, W. Mikulits, M. Schreiber, T. Brabletz, W. Sommergruber, N. Schweifer, A. Wernitznig, H. Beug, R. Foisner, A. Eger, The transcription factor zeb1 (deltaef1) represses plakophilin 3 during human cancer progression. FEBS Lett. 581, 1617–1624 (2007)
24. T.R. Graham, H.E. Zhau, V.A. Odero-Marah, A.O. Osunkoya, K.S. Kimbro, M. Tighiouart, T. Liu, J.W. Simons, R.M. O’Regan, Insulin-like growth factor-i-dependent up-regulation of zeb1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 68, 2479–2488 (2008)
25. S. Spaderna, O. Schmalhofer, F. Hlubek, G. Berx, A. Eger, S. Merkel, A. Jung, T. Kirchner, T. Brabletz, A transient, emt-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131, 830–840 (2006)
26. U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. Zur Hausen, V.G. Brunton, J. Morton, O. Sansom, J. Schuler, M.P. Stemmler, C. Herzberger, U. Hopt, T. Keck, S. Brabletz, T. Brabletz, The emt-activator zeb1 promotes tumorigenicity by repressing stemness-inhibiting micrornas. Nat. Cell Biol. 11, 1487–1495 (2009)
27. H. Guan, G. Wei, J. Wu, D. Fang, Z. Liao, H. Xiao, M. Li, Y. Li, Down-regulation of mir-218-2 and its host gene slit3 cooperate to promote invasion and progression of thyroid cancer. J. Clin. Endocrinol. Metab. 98, E1334–E1344 (2013)
28. Cancer Genome Atlas Research, Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008)
29. B.P. Lewis, C.B. Burge, D.P. Bartel, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 120, 15–20 (2005)
30. A.J. Enright, B. John, U. Gaul, T. Tuschl, C. Sander, D.S. Marks, Microrna targets in drosophila. Genome Biol. 5, R1 (2003)
31. J. Hou, L. Lin, W. Zhou, Z. Wang, G. Ding, Q. Dong, L. Qin, X. Wu, Y. Zheng, Y. Yang, W. Tian, Q. Zhang, C. Wang, Q. Zhang, S.M. Zhuang, L. Zheng, A. Liang, W. Tao, X. Cao, Identification of mirnomes in human liver and hepatocellular carcinoma reveals mir-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19, 232–243 (2011)
32. T. Iwaya, T. Yokobori, N. Nishida, R. Kogo, T. Sudo, F. Tanaka, K. Shibata, G. Sawada, Y. Takahashi, M. Ishibashi, G. Wakabayashi, M. Mori, K. Mimori, Downregulation of mir-144 is associated with colorectal cancer progression via activation of mtor signaling pathway. Carcinogenesis 33, 2391–2397 (2012)
33. Y. Guo, L. Ying, Y. Tian, P. Yang, Y. Zhu, Z. Wang, F. Qiu, J. Lin, Mir-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J. 280, 4531–4538 (2013)
34. S.M. Park, A.B. Gaur, E. Lengyel, M.E. Peter, The mir-200 family determines the epithelial phenotype of cancer cells by targeting the e-cadherin repressors zeb1 and zeb2. Genes Dev. 22, 894–907 (2008)
35. Y. Arima, H. Hayashi, M. Sasaki, M. Hosonaga, T.M. Goto, T. Chiyoda, S. Kuninaka, T. Shibata, H. Ohata, H. Nakagama, Y. Taya, H. Saya, Induction of zeb proteins by inactivation of rb protein is key determinant of mesenchymal phenotype of breast cancer. J. Biol. Chem. 287, 7896–7906 (2012)
36. J. Braun, C. Hoang-Vu, H. Dralle, S. Huttelmaier, Downregulation of micrornas directs the emt and invasive potential of anaplastic thyroid carcinomas. Oncogene 29, 4237–4244 (2010)
37. A. Hebrant, G. Dom, M. Dewaele, G. Andry, C. Tresallet, E. Leteurtre, J.E. Dumont, C. Maenhaut, mrna expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch. PLoS One 7, e37807 (2012)
38. C. Montemayor-Garcia, H. Hardin, Z. Guo, C. Larrain, D. Buehler, S. Asioli, H. Chen, R.V. Lloyd, The role of epithelial mesenchymal transition markers in thyroid carcinoma progression. Endocr. Pathol. 24, 206–212 (2013)
39. F. De Amicis, A. Perri, D. Vizza, A. Russo, M.L. Panno, D. Bonofiglio, C. Giordano, L. Mauro, S. Aquila, D. Tramontano, S. Ando, Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines. J. Cell. Physiol. 228, 2054–2062 (2013)
40. X. Meng, D.H. Kong, N. Li, Z.H. Zong, B.Q. Liu, Z.X. Du, Y. Guan, L. Cao, H.Q. Wang, Knockdown of bag3 induces epithelial-mesenchymal transition in thyroid cancer cells through zeb1 activation. Cell Death Dis. 5, e1092 (2014)